Paraneoplastic neurological degenerations: keys to tumour immunity

This publication has 68 references indexed in Scilit:

• Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy
  Prostate Cancer and Prostatic Diseases, 2004
• Nova Regulates GABA_A Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer
  Molecular and Cellular Biology, 2003
• Cancer immunoediting: from immunosurveillance to tumor escape
  Nature Immunology, 2002
• HuR and mRNA stability
  Cellular and Molecular Life Sciences, 2001
• Normalization of the Tumor Marker CA-125 after Oophorectomy in a Patient with Paraneoplastic Cerebellar Degeneration without Detectable Cancer
  Gynecologic Oncology, 1997
• Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.
  Proceedings of the National Academy of Sciences, 1996
• Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
  Neuron, 1993
• Gynecologic Cancer in Patients With Subacute Cerebellar Degeneration Predicted by Anti-Purkinje Cell Antibodies and Limited in Metastatic Volume
  Mayo Clinic Proceedings, 1990
• Selective Expression of Purkinje-Cell Antigens in Tumor Tissue from Patients with Paraneoplastic Cerebellar Degeneration
  New England Journal of Medicine, 1990
• IMMUNOFLUORESCENT DETECTION OF ANTIBODIES AGAINST NEURONES IN SENSORY CARCINOMATOUS NEUROPATHY
  Brain, 1965